Meeting
2020 Gastrointestinal Cancers Symposium
Real-world treatment patterns and survival in patients (pts) with hepatocellular carcinoma in the United States.
Authors
Michael Morse
Duke University Medical Center, Durham, NC
Michael Morse , Anne-Marie Meyer , Marcus Lawrance , Marta Pereira , Shivani K. Mhatre , Vincent Gaillard , Farshid Dayyani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 519)
Abstract #
519
Poster Bd #
B22
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Treatment patterns and costs among patients with metastatic renal cell carcinoma (mRCC) in the United States: A real-world study using integrated claims and clinical data.
First Author: Daniel M. Geynisman
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world experience and outcomes of hepatocellular carcinoma (HCC) treated with transarterial radioembolization (TARE).
First Author: Parthib Das
Poster
2023 ASCO Annual Meeting
Real-world study of treatment patterns and clinical outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) post-approval of immunotherapy in the community oncology setting.
First Author: Alexander I. Spira
Poster
2023 ASCO Genitourinary Cancers Symposium
Treatment patterns, indicators of receiving systemic treatment, and clinical outcomes in metastatic urothelial carcinoma: A retrospective analysis of real-world data in Germany.
First Author: Guenter Niegisch